Sinclair Pharma PLC (SPH) Insider Jeff Thompson Purchases 150,000 Shares
Sinclair Pharma PLC (LON:SPH) insider Jeff Thompson purchased 150,000 shares of the stock in a transaction that occurred on Tuesday, October 4th. The shares were purchased at an average price of GBX 29 ($0.38) per share, with a total value of £43,500 ($56,781.10).
Sinclair Pharma PLC (LON:SPH) opened at 28.75 on Thursday. The stock’s market capitalization is GBX 142.88 million. Sinclair Pharma PLC has a 12 month low of GBX 26.00 and a 12 month high of GBX 61.33. The firm’s 50-day moving average is GBX 28.94 and its 200-day moving average is GBX 32.00.
A number of equities research analysts recently commented on SPH shares. Royal Bank Of Canada reiterated an “outperform” rating on shares of Sinclair Pharma PLC in a report on Thursday, September 15th. Stifel Nicolaus reiterated a “buy” rating and set a GBX 63 ($0.82) price target on shares of Sinclair Pharma PLC in a report on Wednesday, September 21st. Peel Hunt reiterated a “buy” rating and set a GBX 68 ($0.89) price target on shares of Sinclair Pharma PLC in a report on Tuesday, September 27th. N+1 Singer reiterated a “buy” rating on shares of Sinclair Pharma PLC in a report on Wednesday. Finally, Jefferies Group lowered their price target on shares of Sinclair Pharma PLC from GBX 60 ($0.78) to GBX 55 ($0.72) and set a “buy” rating for the company in a report on Wednesday, June 15th. Five research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus price target of GBX 57 ($0.74).
Sinclair Pharma PLC Company Profile
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Stock Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related stocks with our FREE daily email newsletter.